↓ Skip to main content

Regular treatment with formoterol for chronic asthma: serious adverse events

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

policy
1 policy source
twitter
2 tweeters
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
148 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Regular treatment with formoterol for chronic asthma: serious adverse events
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd006923.pub3
Pubmed ID
Authors

Christopher J Cates, Matthew J Cates

Abstract

Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Germany 1 <1%
South Africa 1 <1%
United Kingdom 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 142 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 20%
Researcher 22 15%
Student > Bachelor 16 11%
Student > Postgraduate 13 9%
Student > Ph. D. Student 13 9%
Other 35 24%
Unknown 19 13%
Readers by discipline Count As %
Medicine and Dentistry 86 58%
Nursing and Health Professions 14 9%
Social Sciences 9 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Agricultural and Biological Sciences 3 2%
Other 12 8%
Unknown 20 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2019.
All research outputs
#2,491,113
of 14,072,211 outputs
Outputs from Cochrane database of systematic reviews
#5,279
of 10,839 outputs
Outputs of similar age
#20,267
of 122,257 outputs
Outputs of similar age from Cochrane database of systematic reviews
#39
of 99 outputs
Altmetric has tracked 14,072,211 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,839 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.6. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 122,257 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.